
Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Seed and early-stage venture capital firm backing science-based technology and life sciences companies

ARCH Venture Partners provides seed and early-stage venture capital for technology companies in information technology, life sciences and physical sciences. It has been investing for more than thirty years and says it founds companies around new scientific ideas that aim to prevent, detect and cure disease.
Scientists and entrepreneurs turning research into companies. Chief executives and chairmen of portfolio companies are quoted on the site describing the firm as an involved partner.
Profile written by TrustList from the business's own published information, Oct 2026.
2 images - click to enlarge
As of 2026-10-11. Organic ranks only; sponsored placements are never ranks.
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about ARCH Venture Partners.
Similar listings buyers compare against this one.

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Venture capital firm backing pre-seed deep technology startups in health and planetary sustainability

Silicon Valley venture capital firm investing from seed to growth stage across technology sectors

Global venture capital firm and accelerator backing early-stage technology founders, formerly called 500 Startups

Decentralised bandwidth network on which developers build and users run censorship-resistant VPN applications

Amazon venture fund investing in voice, artificial intelligence, hardware and entertainment start-ups
Everything here links back to the same verified catalogue. Pick your next stop.